Nature Reviews Drug Discovery
|Nature Reviews Drug Discovery|
|Abbreviated title (ISO 4)||(Nat Rev Drug Discov)|
|Publisher||Nature Publishing Group (international)|
Nature Reviews Drug Discovery is a review journal with an emphasis on drug discovery and development. With an impact factor of 29.008 in 2011 it is the leading journal in pharmacology/pharmacy and biotechnology/applied microbiology areas.
The reviews are commissioned to leaders in the their specialties (non-commissioned review submissions are discouraged), but are also peer-reviewed after submission. The reviews are supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal accepts peer-reviewed analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.
See also 
- Nature Biotechnology, the leading research journal in biotechnology
- Annual Review of Pharmacology and Toxicology and Pharmacological Reviews, two close competitors in the pharmacology area
- Journal Scope : Information : Nature Reviews Drug Discovery. Nature.com (2008-06-20). Retrieved on 2011-06-29.
- Guide : Information : Nature Reviews Drug Discovery. Nature.com. Retrieved on 2011-06-29.
|This article about a medical journal is a stub. You can help Wikipedia by expanding it.
See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.